Chemotherapy vs. "TKI + immunotherapy" in treatment of B-cell acute lymphoblastic leukemia harboring the RCSD1::ABL2 fusion gene. Li Y, Zhang Q, Shao H. Ann Hematol 2024 May 29. doi: 10.1007/s00277-024-05816.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li Y, Zhang Q, Shao H. Chemotherapy vs. "TKI + immunotherapy" in treatment of B-cell acute lymphoblastic leukemia harboring the RCSD1::ABL2 fusion gene. Ann Hematol 2024 May 29. doi: 10.1007/s00277-024-05816.
PMID: 38809455